Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease
NCT02164604
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Retinopathy of Prematurity
Interventions
DRUG:
intravitreal injection of 0.03ml ranibizumab
Sponsor
Kantonsspital Aarau
Collaborators
[object Object]